top of page
molecule of psychedelics.jpg

Current Studies

Reverie is committed to providing patients with access to currently approved treatment options and being a part of researching and studying new therapies. Reverie's studies are reviewed by an ethics committee and comply with Food and Drug Administration guidelines and regulations.



Opioid Use Disorder

This study is for opioid use disorder (OUD). Reverie is working with a company to validate a technology tool to help individuals with OUD that provides greater and potentially beneficial support to patients with OUD.


Major Depressive Disorder with Suicidal Ideation

Reverie is working with a company to further evaluate their therapy for patients who have a major depressive disorder (MDD) and have suicidal ideation or the intention to harm themselves. 

bottom of page